Press release
Peptide Based Hematological Disorders Therapeutics Industry Outlook and Market Development Analysis Reveals Forecast for the Period 2017-2022
Fact.MR
Get A Free Sample Copy of Report@ https://www.factmr.com/connectus/sample?flag=S&rep_id=189
North America Market Set to Dominate the Global Peptide Based Hematological Disorders Therapeutics Market in Terms of Revenue
The market in North America is set to dominate the global peptide based hematological disorders therapeutics market in terms of value and this trend is projected to sustain itself throughout the assessment period. North America peptide based hematological disorders therapeutics market is the most attractive market, growing at a robust CAGR over the assessment period.
Icatibant Segment Poised to Touch a Value of Nearly US$ 410 Mn in 2022
As per the forecast of Fact.MR, the icatibant segment is expected to reach a value of nearly US$ 410 Mn in the year 2022. This represents a robust CAGR during the forecast period of 2017-2022. Icatibant segment is expected to account for more than three-fourth of the revenue share of the drug segment by the year 2017 and is expected to lose market share by the end of the year 2022.
Hospital Pharmacies Segment to exhibit a CAGR of 7.4% During the Assessment Period
As per the forecast of Fact.MR, the hospital pharmacies segment is slated to touch a figure of nearly US$ 260 Mn in the year 2022. This represents a CAGR of 7.4% during the assessment period from 2017 till the year 2022. This segment is expected to lose market share by the end of the year 2022. The hospital pharmacies segment is expected to account for more than half of the revenue share of the distribution channel segment by the year 2017.
Competition Tracking
The report also profiles companies that are expected to remain active in the expansion of global peptide based hematological disorders therapeutics market through 2022, which includes Shire plc.
Browse Full Report with TOC@ https://www.factmr.com/report/189/peptide-based-hematological-disorders-therapeutics-market
Table of Contents:
Global Peptide Based Hematological Disorders Therapeutics Market – Executive Summary
Global Peptide Based Hematological Disorders Therapeutics Market Overview
2.1. Introduction
2.1.1. Global Peptide Based Hematological Disorders Therapeutics Market Taxonomy
2.1.2. Global Peptide Based Hematological Disorders Therapeutics Market Definition
2.2. Global Peptide Based Hematological Disorders Therapeutics Market Size (US$ Mn) and Forecast, 2012-2022
2.2.1. Global Peptide Based Hematological Disorders Therapeutics Market Y-o-Y Growth
2.3. Global Peptide Based Hematological Disorders Therapeutics Market Dynamics
2.4. Regulations
2.5. Supply Chain
2.6. Cost Structure
2.7. Average Pricing Analysis
2.8. Epidemiology
2.9. Key Participants Market Presence (Intensity Map) By Region
Global Peptide Based Hematological Disorders Therapeutics Market Analysis and Forecast By Drug
3.1. Global Peptide Based Hematological Disorders Therapeutics Market Size and Forecast By Drug, 2012-2022
3.1.1. Icatibant Peptide Based Hematological Disorders Therapeutics Market Size and Forecast, 2012-2022
3.1.1.1. Revenue (US$ Mn) Comparison, By Region
3.1.1.2. Market Share Comparison, By Region
3.1.1.3. Y-o-Y growth Comparison, By Region
Continued………..
Check Discount on this Report@ https://www.factmr.com/connectus/sample?flag=D&rep_id=189
About Fact.MR
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized healthcare market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that’s why we publish multi-industry global, regional, and country-specific research reports.
Contact Us
Fact.MR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Peptide Based Hematological Disorders Therapeutics Industry Outlook and Market Development Analysis Reveals Forecast for the Period 2017-2022 here
News-ID: 1035562 • Views: …
More Releases from Fact.MR
Hemoglobinopathy Market Forecast Growing at 8.3% CAGR to Reach $1.7 Billion by 2 …
In 2024, the global hemoglobinopathy market (ヘモグロビン症市場) is estimated to be worth US$788.1 million, with a projected compound annual growth rate (CAGR) of 8.3% through 2034. By 2034, the market size is expected to exceed US$1,745.7 million. The rise of genetic testing has led to a significant shift in the hemoglobinopathy market towards personalized medication. Companies are leveraging this trend to develop tailored treatment plans based on each patient's DNA…
Sales Forecast of Elder Care Product Market to Reach US$ 56.7 Billion by 2034 wi …
The global elder care product market (高齢者介護製品市場) is anticipated to reach a value of US$ 29,600.2 million by 2024 and is expected to exceed US$ 56,719.4 million by 2034. Sales of these products are forecasted to grow at a CAGR of 6.7% through 2034, driven by the growing trend of aging-in-place. This trend is fueling innovations in technology integration, wearable health devices, and personalized safety solutions. Increasing awareness about elder…
Veterinary Oncology Market Predicts 12% CAGR Through 2033 With a US$ 800 Million
In 2023, the veterinary oncology market (獣医腫瘍学市場) was valued at US$ 260 million, and it's anticipated to reach US$ 800 million by the end of 2033, with a projected compound annual growth rate (CAGR) of 12% from 2023 to 2033. Veterinary oncology focuses on caring for pets diagnosed with cancer, with the goal of enhancing their overall quality of life. Cancer is the leading cause of mortality among companion animals,…
Sales of Luxury Eyewear are forecasted to reach US$ 56 billion by 2033
According to Fact.MR, a trusted provider of market research and competitive intelligence, the global Luxury Eyewear Market was valued at US$ 40 billion in 2023. Projections suggest that by the conclusion of 2033, this market is anticipated to escalate to US$ 56 billion. Forecasts indicate a steady Compound Annual Growth Rate (CAGR) of 3.4% in the global demand for luxury eyewear from 2023 to 2033.
The surge in luxury eyewear sales…
More Releases for Peptide
Peptide Modifications For PEGylation
PEGylation is the process of covalently attaching polyethylene glycol (PEG) polymer chains to peptides. By increasing their molecular mass and shielding them from proteolytic enzymes, PEGylation improves the pharmacokinetics of peptides and proteins. PEGylation reduces renal clearance and results in more sustained absorption after subcutaneous administration, as well as restricted distribution. PEGylations have been shown to significantly improve water solubility, biocompatibility, immunogenicity, and other physico-chemical properties. It is an established…
What's driving the Customized Peptide Synthesis Market Growth? | Key Players are …
The customized peptide synthesis market is projected to generate a revenue of $390.0 million by 2024 as per a recent P&S Intelligence study. The market is being progressively driven by technological innovations, growing burden of cancer and infectious diseases, increasing investments and funding for protein-based research, and rising research activities in synthetic biology.
Download free report sample at: https://www.psmarketresearch.com/market-analysis/customized-peptide-synthesis-market/report-sample
There are two main types of products available in the customized peptide synthesis…
Customized Peptide Synthesis Market 2019-2024 by Top Key Players are GenScript, …
Customized peptide synthesis market is forecasted to generate revenue of $390.0 million by 2024. The market is mainly driven by increasing investments and funding for protein-based research, technological innovations, growing burden of cancer and infectious diseases, and increasing research activities in the field of synthetic biology.
Download free report sample at: https://www.psmarketresearch.com/market-analysis/customized-peptide-synthesis-market/report-sample
The different types of products available in the customized peptide synthesis market are reagents and equipment. Reagents category is expected…
Peptide Synthesis Market Increasing Demand & Latest Trend with Genscript, AnaSpe …
HTF MI recently introduced United States Peptide Synthesis Market study with in-depth overview, describing about the Product / Industry Scope and elaborates market outlook and status to 2023. The market Study is segmented by key regions which is accelerating the marketization. At present, the market is developing its presence and some of the key players from the complete study are Bachem, PolyPeptide, GL Biochem, Xinbang, Hybio, USVPeptides, Thermofischer, ScinoPharm, Genscript,…
Global Peptide Therapeutics Market: Cancer Treatment to Surface as Key Applicati …
Market Research Reports Search Engine (MRRSE) has been acting as an impressive data source when it comes to evaluating various industrial verticals. The research report titled “Global Peptide Therapeutics Market” offers a clear insight about the Peptide Therapeutics assessed over the global platform. This analysis proves beneficial for readers & new investors who are aiming to enter the market for Peptide Therapeutics in the near future.
Click to Request a Sample:…
Peptide Based Cancer Therapeutics Marke For peptide based cancer therapeutics ov …
About Peptide Based Cancer Therapeutics Market
Popularity of peptide based cancer therapeutics is on the rise, owing to the positive outlook on their efficiency in treating cancer. According to the latest report published by Fact.MR, the global market for peptide based cancer therapeutics is set to reflect an above average CAGR during 2017 to 2022, to reach a valuation in excess of US$ 11,100 Mn. Incessant development in drug…
